倾向得分匹配
医学
内科学
结直肠癌
肿瘤科
辅助化疗
队列研究
新辅助治疗
化疗
队列
佐剂
回顾性队列研究
前瞻性队列研究
外科
匹配(统计)
癌症
梅德林
辅助治疗
总体生存率
临床试验
氟尿嘧啶
作者
Koji Fukata,Atsushi Ogura,Yuki Murata,Ryutaro Kobayashi,Shoji Kawakatsu,Shizuki Sugita,Shunsuke Onoe,Kazushi Miyata,Junpei Yamaguchi,Takashi Mizuno,Tomoki Ebata
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2025-09-26
卷期号:45 (10): 4431-4439
标识
DOI:10.21873/anticanres.17791
摘要
Background/Aim: Total neoadjuvant therapy has been widespread over the past years and the multimodal treatment strategy involving administration of neoadjuvant chemotherapy (NAC) gradually increases for patients with locally advanced rectal cancer. However, the necessity of adjuvant chemotherapy (AC) following NAC remains controversial. The aim of this study was to investigate the impact of AC on survival outcomes and the influence of perioperative chemotherapy on treatment efficacy in patients with locally advanced rectal cancer (LARC) who received NAC followed by surgery. Patients and Methods: We retrospectively analyzed 107 patients with LARC who received NAC using propensity score matching (PSM) with covariates of clinical N stage, anus-preserving status, presence of severe complications (≥ Clavien-Dindo 3). All patients were planned and treated for three months with oxaliplatin-based doublet chemotherapy preoperatively. Results: There were no significant differences between AC and Non-AC groups in 50 patients of the PSM cohort. At a median follow-up of 85.6 months, the 5-year overall survival was 88.0% and the 5-year relapse-free survival (RFS) was 81.3% for the entire cohort. The 5-year RFS was significantly better in the AC than in the non-AC group (87.3% vs. 79.8%, p=0.033). Multivariate analysis demonstrated that non-AC and lateral lymph node metastasis were poor prognostic factors of RFS in patients with LARC [non-AC: Hazard ratio (HR)=4.089, 95% confidence interval (CI)=1.217-13.735, p=0.023; lateral lymph node metastasis: HR=9.04, 95%CI=1.737-47.040, p=0.009]. Conclusion: AC could improve RFS in patients with LARC following NAC.
科研通智能强力驱动
Strongly Powered by AbleSci AI